S&P 500
(0.72%) 5 054.65 points
Dow Jones
(0.68%) 38 162 points
Nasdaq
(1.23%) 15 797 points
Oil
(0.04%) $79.03
Gas
(5.33%) $2.04
Gold
(0.02%) $2 311.40
Silver
(0.68%) $26.93
Platinum
(1.22%) $966.55
USD/EUR
(-0.04%) $0.933
USD/NOK
(-0.30%) $11.00
USD/GBP
(-0.04%) $0.798
USD/RUB
(-1.36%) $91.99

实时更新: Abbott Laboratories [ABT]

交易所: NYSE 部门: Healthcare 工业: Medical - Devices
最后更新时间3 May 2024 @ 01:47

-0.24% $ 106.03

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 01:47):

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices...

Stats
今日成交量 1.69M
平均成交量 5.67M
市值 183.98B
EPS $0 ( 2024-04-17 )
下一个收益日期 ( $1.100 ) 2024-07-18
Last Dividend $0.550 ( 2024-04-12 )
Next Dividend $0 ( N/A )
P/E 33.03
ATR14 $0.0500 (0.05%)
Insider Trading
Date Person Action Amount type
2024-04-26 Stratton John G Buy 1 866 Common shares without par value
2024-04-26 Starks Daniel J Buy 1 866 Common shares without par value
2024-04-26 Starks Daniel J Buy 5 277 Option (right to buy)
2024-04-26 Roman Michael F Buy 1 866 Common shares without par value
2024-04-26 O'grady Michael Buy 4 404 Option (right to buy)
INSIDER POWER
55.29
Last 99 transactions
Buy: 1 141 010 | Sell: 385 716

音量 相关性

長: -0.09 (neutral)
短: 0.18 (neutral)
Signal:(57.496) Neutral

Abbott Laboratories 相关性

10 最正相关
ULE0.948
FXE0.947
UDN0.941
EWN0.937
BWX0.936
DRI0.935
NERD0.934
LEMB0.932
EMLC0.932
BYM0.931
10 最负相关
EUO-0.946
UUP-0.923
TNK-0.916
USDU-0.909
DEX-0.902
TYO-0.893
PST-0.892
TBX-0.886
TMV-0.883
MIE-0.883

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Abbott Laboratories 相关性 - 货币/商品

The country flag -0.32
( neutral )
The country flag -0.77
( moderate negative )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )
The country flag -0.75
( moderate negative )
The country flag 0.74
( moderate )

Abbott Laboratories 财务报表

Annual 2023
营收: $40.11B
毛利润: $22.13B (55.18 %)
EPS: $3.30
FY 2023
营收: $40.11B
毛利润: $22.13B (55.18 %)
EPS: $3.30
FY 2022
营收: $43.65B
毛利润: $24.51B (56.15 %)
EPS: $3.94
FY 2021
营收: $43.08B
毛利润: $24.54B (56.97 %)
EPS: $3.99

Financial Reports:

No articles found.

Abbott Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.470
(N/A)
$0.470
(N/A)
$0.510
(N/A)
$0.510
(N/A)
$0.510
(N/A)
$0.510
(N/A)
$0.550
(N/A)
$0.550
(N/A)
$0
(N/A)
$0
(N/A)

Abbott Laboratories Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.81 - low (59.75%) | Divividend Growth Potential Score: 6.17 - Stable (23.43%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.00589 1983-01-11
Last Dividend $0.550 2024-04-12
Next Dividend $0 N/A
Payout Date 2024-05-15
Next Payout Date N/A
# dividends 166 --
Total Paid Out $25.20 --
Avg. Dividend % Per Year 1.43% --
Score 4.72 --
Div. Sustainability Score 4.81
Div.Growth Potential Score 6.17
Div. Directional Score 5.49 --
Next Divdend (Est)
(2024-07-02)
$0.557 Estimate 74.91 %
Dividend Stability
1.00 Excellent
Dividend Score
4.72
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1983 $0.0269 2.59%
1984 $0.0323 2.50%
1985 $0.0379 3.32%
1986 $0.0452 2.37%
1987 $0.0398 1.49%
1988 $0.0644 2.36%
1989 $0.0756 2.82%
1990 $0.0904 2.32%
1991 $0.108 2.22%
1992 $0.129 1.71%
1993 $0.148 2.17%
1994 $0.166 2.57%
1995 $0.184 2.50%
1996 $0.209 2.23%
1997 $0.296 2.62%
1998 $0.263 1.73%
1999 $0.296 1.35%
2000 $0.332 2.11%
2001 $0.368 1.70%
2002 $0.409 1.63%
2003 $0.435 2.42%
2004 $0.477 2.27%
2005 $0.521 2.33%
2006 $0.558 2.94%
2007 $0.610 2.60%
2008 $0.675 2.52%
2009 $0.749 2.91%
2010 $0.825 3.16%
2011 $0.901 3.93%
2012 $0.965 3.55%
2013 $0.560 1.75%
2014 $0.880 2.30%
2015 $0.960 2.14%
2016 $1.040 2.42%
2017 $1.060 2.71%
2018 $1.120 1.91%
2019 $1.280 1.84%
2020 $1.440 1.66%
2021 $1.800 1.65%
2022 $1.880 1.35%
2023 $2.04 1.86%
2024 $1.100 1.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
GOF Dividend Royal 2023-11-14 Monthly 18 8.03% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
ZTR Dividend Royal 2024-02-09 Monthly 37 8.35% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1401.5007.2110.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1481.5009.4710.00[0.1 - 1]
payoutRatioTTM0.474-1.0005.26-5.26[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM10.861.0007.097.09[3 - 30]
operatingCashFlowPerShareTTM3.532.008.8210.00[0 - 30]
freeCashFlowPerShareTTM2.482.008.7610.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.5411.0004.314.31[0.2 - 0.8]
operatingProfitMarginTTM0.1671.0008.658.65[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.81

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM32.741.0006.790[1 - 100]
returnOnEquityTTM0.1482.509.6610.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.482.009.1710.00[0 - 30]
dividendYielPercentageTTM1.9951.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM3.532.008.8210.00[0 - 30]
payoutRatioTTM0.4741.5005.26-5.26[0 - 1]
pegRatioTTM0.3321.500-1.1220[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1521.0008.710[0.1 - 0.5]
Total Score6.17

Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。